Clinical trial

Study of Anti-r-HuEpo Associated Pure Red Cell Aplasia (PRCA) Treatment

NCT01288131

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-01-01

PhasePHASE3

Study timeline

Study start (unknown)2009-01-01Date precision: month

Registry last updated2014-01-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Anti-r-HuEpo Associated PRCA Subjectsunresolved

Interventions

Cyclosporine combine with mycophenolate mofetilDRUG

Cyclophosphamide + predDRUG

Sponsors & collaborators

Chulalongkorn Universitylead sponsor

Mapped research locations

BangkokThailand1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01288131 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.